CAS 2688-77-9
:laudanosina
- (1S)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline
- (1S)-1-[(3,4-Dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methylisoquinoline
- (S)-(+)-Laudanosine
- 1-(3,4-Dimethoxybenzyl)-6,7-Dimethoxy-2-Methyl-1,2,3,4-Tetrahydroisoquinoline
- <span class="text-smallcaps">L</span>-(+)-Laudanosine
- DL-6,7-dimethoxy-1-((3,4-dimethoxyphenyl)methyl)-2-methylisoquinoline
- DL-laudanosine
- Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1S)-
- Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (S)-
- NSC 35045
- O-Methylcodamine
- Laudanosine
- Einecs 220-253-2
- (1S)-1,2,3,4-Tetrahydro-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methylisoquinoline
- Cisatracurium Besylate Impurity 49
- Vedi altri sinonimi
(S)-Laudanosine
CAS:(S)-Laudanosine is the corresponding isomer of Laudanosine, which crosses the blood-brain barrier, with potential systemic toxicity and analgesic effects.Formula:C21H27NO4Purezza:99.86%Colore e forma:SolidPeso molecolare:357.44(S)-Laudanosine
CAS:Prodotto controllatoApplications Laudanosine is a metabolite of the neuromuscular-blocking drugs Atracurium (A794500) and Cisatracurium (C496700) with potentially toxic systemic effects. It crosses the blood-brain barrier and may cause excitement and seizure activity.
References Canfell, P., et al.: Drug Metab. Dispos., 14, 703 (1986), Anselmi, E., et al.: J. Pharm. Pharmacol., 44, 337 (1992), Bohrer, H., et al.: Pharmacol. Toxicol., 73, 137 (1993),Formula:C21H27NO4Colore e forma:NeatPeso molecolare:357.44Ref: ST-EA-CP-A131069
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta(S)-Laudanosine
CAS:Laudanosine is a gamma-aminobutyric acid (GABA) analog that is metabolized by the liver to form laudanosine. Laudanosine has been shown to be a competitive antagonist of benzodiazepine binding sites, including those of atracurium, mivacurium chloride, and diazepam. Laudanosine has also been shown to inhibit cyclic nucleotide phosphodiesterases in vitro, with clinical relevance for its use as an anti-epileptic drug.
Formula:C21H27NO4Purezza:Min. 95%Peso molecolare:357.44 g/mol





